Sécukinumab - COSENTYX 150 mg, solution injectable en seringue préremplie

Business Listing - December 25, 2019

Sécukinumab COSENTYX 150 mg, solution injectable en seringue préremplie - L04AC10 NOVARTIS EUROPHARM (ROYAUME-UNI) - 63549069

This is a premium business listing. Stand out from the competition!

List your company and reach more customers today.